Results 111 to 120 of about 146,670 (267)

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

What Are the Impacts of GLP‐1 Drugs in Patients Needing Head/Neck Surgery?

The Laryngoscope, EarlyView.
Chelsea Gelboin‐Burkhart, Liam Gallagher, Bridget Ebert, Samir S. Khariwala   +3 more
wiley   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna, Carlos Mena‐Hurtado, Victoria Divino, Zhenxiang Zhao, Yan Chen, Joanna Boland, Jinlin Song, Andrea Traina, Kerem Ozer, Filip K. Knop, Kim G. Smolderen   +10 more
wiley   +1 more source

Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumor with lymph node metastasis: A case report [PDF]

, 2011
Introduction Papillary thyroid carcinoma and medullary thyroid carcinoma are two different thyroid neoplasia. The simultaneous occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma as a collison tumor with metastases from both lesions
Mehr Sadat Alavi, Negar Azarpira
core   +2 more sources

Time to calcitonin normalization after surgery for node‐negative and node‐positive medullary thyroid cancer

British Journal of Surgery, 2019
It remains unclear when postoperative serum calcitonin levels should be measured in patients with medullary thyroid cancer (MTC) and, specifically, whether this decision should be based on the preoperative calcitonin level or nodal status.
Andreas Machens, K. Lorenz, H. Dralle, H. Dralle   +3 more
semanticscholar   +1 more source

Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis

Journal of Periodontal Research, EarlyView.
A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Groeger Sabine Elisabeth, Zhou Yuxi, Yong Jiawen, Wang Lei, Ruf Sabine, Meyle Joerg   +5 more
wiley   +1 more source

Targeted Therapy for Medullary Thyroid Cancer: A Review

Frontiers in Oncology, 2017
Medullary thyroid cancers (MTCs) constitute between 2 and 5% of all thyroid cancers. The 10-year overall survival (OS) rate of patients with localized disease is around 95% while that of patients with regional stage disease is about 75%.
S. R. Priya, S. R. Priya, Chandra Shekhar Dravid, Chandra Shekhar Dravid, Raghunadharao Digumarti, Raghunadharao Digumarti, Mitali Dandekar   +6 more
doaj   +1 more source

Medullary thyroid cancer (MTC): Risk Factors for Recurrence and Prognostic Variables that Influence Outcome

SVU - International Journal of Medical Sciences
Background: Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor from thyroid C cells that can cause thyroid lumps or metastases. MTC accounts for 10.5% of metastasized thyroid tumors and is linked to RET proto-oncogene mutations.
Ayman A. Amin , Hamdy Mohamed Hussein , Ahmed K. Fekry *, Mohamed Mubarak   +3 more
doaj   +1 more source

Medullary thyroid cancer treated with vandetanib: predictors of longer and durable response.

Endocrine-Related Cancer, 2019
Vandetanib is an important option to treat advanced metastatic medullary thyroid cancer. The aims of this study were to evaluate the predictors of both a longer response to vandetanib and of their outcome.
L. Valerio, V. Bottici, A. Matrone, P. Piaggi, D. Viola, V. Cappagli, L. Agate, E. Molinaro, R. Ciampi, A. Tacito, T. Ramone, C. Romei, R. Elisei   +12 more
semanticscholar   +1 more source

A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal [PDF]

, 2010
The prognosis of medullary thyroid carcinoma (MTC) depends on the completeness of the first surgical treatment. To date, it is not possible to predict whether the tumor has been completely removed after surgery.
A. Colao, A. Faggiano, American Thyroid Association Guidelines Task Force, Kloos, Costante, Dralle, Dralle, F. Milone, G. Lombardi, Gharib, Grauer, I. Ventre, Inabnet, L. Pezzullo, Leboulleux, M. G. Chiofalo, Machens, Machens, Machens, Moley, R. Giannattasio, R. Severino, Rago, Scheuba, Scollo, V. Ramundo, Wells Jr   +25 more
core   +1 more source